4//SEC Filing
SCHIERMEIER ANDREW 4
Accession 0001209191-21-000584
CIK 0001652130other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:03 PM ET
Size
7.2 KB
Accession
0001209191-21-000584
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2020-12-30−1,500→ 148,500 totalExercise: $13.48Exp: 2027-01-02→ Common Stock (1,500 underlying) - Exercise/Conversion
Common Stock
2020-12-30$13.48/sh+1,500$20,220→ 12,673 total
Footnotes (2)
- [F1]Includes 857 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2020.
- [F2]The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 146,875 shares as of December 30, 2020.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001738456
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:03 PM ET
- Size
- 7.2 KB